HAVLF
HAVN Life Sciences Inc.
Set alert
0.00 USD 0.00 0.00%
0.01 Day range 0.01
0.00001 52-week range 0.01
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.01
- Prev close
- 0.0001
- Mkt cap
- 1.47K
- Vol
- 22.11K
- Avg vol
- 0
- EPS
- -2.37
- P/E
- 0.00
More statistics
- Low
- 0.01
- High
- 0.01
Financial health
Altman Z-Score
-96.84 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2020 5y median -2.5× FY 2022
P/S 29.8×
FY 2020 5y median 0.0× FY 2022
P/B 2.6×
FY 2020 5y median 5.9× FY 2022
P/FCF -1.0×
FY 2020 5y median -7.4× FY 2022
EV/EBITDA -1.0×
FY 2020 5y median -1.0× FY 2022
EV/Sales 27.4×
FY 2020 5y median 0.0× FY 2022
FCF Yield -96.7%
FY 2020 5y median -13.5% FY 2022
Profitability
Gross Margin 32.4%
FY 2020 5y median 0.0% FY 2022
Operating Margin -3548.4%
FY 2020 5y median 0.0% FY 2022
Net Margin -8117.8%
FY 2020 5y median 0.0% FY 2022
ROE -714.6%
FY 2020 5y median -230.2% FY 2022
ROIC -277.9%
FY 2020 5y median -222.3% FY 2022
ROA -552.9%
FY 2020 5y median -213.3% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2022
Operating Income 67.7%
FY 2020 FY 2022
EPS (diluted) 38.0%
FY 2020 FY 2022
Free Cash Flow 23.7%
FY 2020 FY 2022
Financial Health
Current Ratio 4.5×
FY 2020 5y median 14.8× FY 2022
Quick Ratio 2.6×
FY 2020 5y median 14.3× FY 2022
Debt / Equity 0.1×
FY 2020 5y median 0.0× FY 2022
Net Debt / EBITDA 0.1×
FY 2020 5y median 0.1× FY 2022
Interest Coverage -153×
FY 2020 5y median -153× FY 2022
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-04-30